Atlanta Consulting Group Advisors LLC purchased a new stake in Oracle Co. (NYSE:ORCL – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 9,069 shares of the enterprise software provider’s stock, valued at approximately $1,545,000.
A number of other hedge funds and other institutional investors have also modified their holdings of ORCL. Fairway Wealth LLC acquired a new position in Oracle in the second quarter valued at about $27,000. POM Investment Strategies LLC acquired a new stake in Oracle in the 2nd quarter valued at approximately $30,000. Bbjs Financial Advisors LLC acquired a new position in Oracle during the second quarter worth $35,000. Koesten Hirschmann & Crabtree INC. purchased a new position in Oracle during the 1st quarter valued at about $38,000. Finally, Quest Partners LLC purchased a new position in shares of Oracle in the second quarter valued at approximately $40,000. 42.44% of the stock is owned by institutional investors and hedge funds.
Oracle Stock Performance
NYSE:ORCL opened at $183.74 on Friday. The firm’s fifty day simple moving average is $172.14 and its 200-day simple moving average is $146.83. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 6.68. The stock has a market cap of $509.15 billion, a PE ratio of 47.36, a price-to-earnings-growth ratio of 3.39 and a beta of 1.02. Oracle Co. has a fifty-two week low of $99.26 and a fifty-two week high of $191.77.
Oracle Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, October 24th. Shareholders of record on Thursday, October 10th were given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.87%. The ex-dividend date was Thursday, October 10th. Oracle’s payout ratio is 41.24%.
Analysts Set New Price Targets
Several equities research analysts have weighed in on ORCL shares. UBS Group restated a “market outperform” rating on shares of Oracle in a report on Friday, October 18th. Guggenheim raised their price objective on shares of Oracle from $185.00 to $200.00 and gave the company a “buy” rating in a report on Friday, September 13th. Jefferies Financial Group boosted their target price on shares of Oracle from $170.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, September 16th. KeyCorp raised their target price on Oracle from $190.00 to $200.00 and gave the stock an “overweight” rating in a research report on Friday. Finally, Mizuho boosted their price target on shares of Oracle from $170.00 to $185.00 and gave the company an “outperform” rating in a research report on Tuesday, September 10th. Eleven equities research analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $169.52.
Check Out Our Latest Report on ORCL
Insider Transactions at Oracle
In other news, EVP Maria Smith sold 6,320 shares of Oracle stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $165.00, for a total transaction of $1,042,800.00. Following the completion of the sale, the executive vice president now directly owns 42,889 shares in the company, valued at $7,076,685. The trade was a 12.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 42.20% of the company’s stock.
Oracle Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Read More
- Five stocks we like better than Oracle
- Health Care Stocks Explained: Why You Might Want to Invest
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Quiet Period Expirations Explained
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What is the S&P 500 and How It is Distinct from Other Indexes
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.